Nature's Miracle Pivots from Ag-Tech to US Drone Manufacturing

ONTARIO, Calif. – May 21, 2026 – Nature's Miracle Holding Inc., a company primarily known for its role in controlled environment agriculture, today announced a significant strategic pivot with a letter of intent to acquire a majority stake in a trio of Chicago-area manufacturing, design, and e-commerce firms. The move signals a bold expansion from vertical farming solutions into the burgeoning and strategically critical markets of U.S.-made drones and AI data center hardware.

The company (OTCID: NMHI) has entered into a non-binding Letter of Intent (LOI) to acquire a 55% equity interest in CM Fabrication, LLC, CEA Studios, and CM E-Commerce LLC. The centerpiece of the deal is CM Fabrication, which operates a sprawling 500,000-square-foot advanced manufacturing facility in Sycamore, Illinois. The proposed transaction is valued at approximately $11 million, which will be sourced from a third-party lender and is primarily intended to refinance about $10 million of the target companies' existing debt.

A Strategic Leap into Advanced Manufacturing

For Nature's Miracle, this acquisition represents a fundamental diversification of its business model. While the company has established itself by providing equipment and services for indoor farming, this deal propels it directly into the industrial manufacturing sector. The acquisition of CM Fabrication provides an immediate, large-scale domestic production capability that aligns with a recent strategic partnership to develop AI-powered robotics.

"We are excited about the potential combination between Nature's Miracle and the CM Capital portfolio companies," said Tie "James" Li, Chairman and Chief Executive Officer of Nature's Miracle, in a statement. He noted CM Fabrication's reputation in horticulture but emphasized the expansion into a more critical arena. "Acquisition of CM Fabrication gives us the capability to manufacture drone in the U.S. which is critical in the global supply chain."

This move is intended to create a vertically integrated platform. CM Fabrication brings precision metalwork, robotic welding, and electronics manufacturing. It is complemented by CEA Studios, which provides architectural and design services, and CM E-Commerce, which manages online distribution. Together, they form a unit capable of designing, building, and selling complex American-made equipment.

Tapping the 'Made-in-USA' Imperative

The deal is strategically timed to capitalize on a growing government and commercial emphasis on reshoring critical manufacturing. With mounting concerns over global supply chain vulnerabilities and national security, the demand for domestically produced drones and data center components has surged. CM Fabrication's Illinois facility positions the combined company to compete for contracts where U.S. origin is a key requirement.

Chris Mayer, the founder of CM Fabrication who is expected to assume a senior C-level role in the new structure, highlighted this focus. "We are excited to partner with Nature's Miracle and pursue a public listing strategy to access growth capital for the rapidly expanding advanced manufacturing opportunities within the drone, AI data center and energy sectors in the United States," he commented. Mayer also pointed to leveraging Nature's Miracle's existing supply chain to improve operational efficiency.

The market for U.S.-built drones is expanding beyond defense applications into agriculture, energy, and logistics, while the boom in artificial intelligence is driving unprecedented demand for the specialized server racks and cooling infrastructure that power data centers. By acquiring CM Fabrication, Nature's Miracle is placing a significant bet on the long-term growth of these high-tech, high-stakes industries.

Ambitious Projections and a High-Stakes Financial Play

The proposed acquisition comes with aggressive growth expectations. The target companies collectively generated approximately $8.6 million in revenue and a modest $80,000 in EBITDA in 2025. However, they are projecting a more than twofold increase in revenue to $18.2 million and a dramatic surge in EBITDA to $3.6 million for 2026, suggesting significant new contracts or operational turnarounds are anticipated.

To fund this future growth, Nature's Miracle plans an ambitious financial maneuver: pursuing an uplisting from the OTC markets to a major exchange like the Nasdaq or NYSE. The strategy involves merging with a listed shell company, a path often seen as a faster but riskier alternative to a traditional IPO. A successful uplisting would grant the company access to a much larger pool of institutional investors and capital, but the process is fraught with regulatory scrutiny.

Nature's Miracle has committed to eventually acquiring the remaining 45% of the companies from CM Capital Management at a valuation of at least $20 million or ten times the trailing EBITDA, locking in a path to full ownership.

Navigating Financial Headwinds and Future Hurdles

While the strategic vision is clear, the path forward contains notable challenges. The entire transaction is contingent upon the signing of a definitive agreement, which has not yet occurred. Furthermore, Nature's Miracle itself has recently navigated financial reporting complexities. The company disclosed a delay in filing its quarterly report for the period ending March 31, 2026, and earlier had to restate past financial statements due to an accounting omission.

Such issues could attract heightened scrutiny from regulators and investors as the company attempts its uplisting. The success of this ambitious venture will ultimately hinge on the successful negotiation of a definitive agreement, securing the planned financing, and carefully navigating the complex financial and regulatory landscape ahead.